DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 5, Pages 473
Publisher
MDPI AG
Online
2021-05-18
DOI
10.3390/ph14050473
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA aptamers targeting Leishmania infantum H3 protein as potential diagnostic tools
- (2020) Valerio Frezza et al. ANALYTICA CHIMICA ACTA
- RHOA and mDia1 promotes apoptosis of breast cancer cells via a high dose of doxorubicin treatment
- (2020) Peter Bober et al. Open Life Sciences
- Clarithromycin effectively enhances doxorubicin-induced cytotoxicity and apoptosis in MCF7 cells through dysregulation of autophagy
- (2020) Nahid Amani et al. Advances in Medical Sciences
- Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?
- (2018) Ignacio Campillo-Marcos et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- High expression of VRK1 is related to poor prognosis in glioma
- (2018) Zhiyun Ben et al. PATHOLOGY RESEARCH AND PRACTICE
- Aptamers: novelty tools for cancer biology
- (2018) Ricardo L. Pereira et al. Oncotarget
- Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells
- (2018) Aye M. Mon et al. PLoS One
- Aptamers as targeted therapeutics: current potential and challenges
- (2017) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage
- (2016) Diana M. Monsalve et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol–Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non–Small Cell Lung Cancer In Vitro
- (2016) Mona Alibolandi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation
- (2016) Takuyu Hashiguchi et al. MOLECULAR ENDOCRINOLOGY
- High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma
- (2016) Wei Huang et al. PATHOLOGY RESEARCH AND PRACTICE
- Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation
- (2016) David S. Moura et al. Scientific Reports
- VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage
- (2015) Marcella Salzano et al. Epigenetics
- Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition
- (2015) Namgyu Lee et al. Oncotarget
- AS1411-conjugated gold nanospheres and their potential for breast cancer therapy
- (2015) Mohammad T. Malik et al. Oncotarget
- Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response
- (2015) Marcella Salzano et al. Oncotarget
- VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage
- (2014) Inmaculada López-Sánchez et al. FEBS LETTERS
- Depletion of the protein kinase VRK1 disrupts nuclear envelope morphology and leads to BAF retention on mitotic chromosomes
- (2014) Tyler P. Molitor et al. MOLECULAR BIOLOGY OF THE CELL
- Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo
- (2013) T P Molitor et al. Oncogenesis
- Vaccinia-related Kinase 1 (VRK1) Is an Upstream Nucleosomal Kinase Required for the Assembly of 53BP1 Foci in Response to Ionizing Radiation-induced DNA Damage
- (2012) Marta Sanz-García et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Roles of VRK1 as a new player in the control of biological processes required for cell division
- (2011) Alberto Valbuena et al. CELLULAR SIGNALLING
- The complexity of phosphorylated H2AX foci formation and DNA repair assembly at DNA double-strand breaks
- (2010) Asako J. Nakamura et al. CELL CYCLE
- Mice Deficient in the Serine/Threonine Protein Kinase VRK1 Are Infertile Due to a Progressive Loss of Spermatogonia1
- (2009) Matthew S. Wiebe et al. BIOLOGY OF REPRODUCTION
- Therapeutic Applications of DNA and RNA Aptamers
- (2009) Kristina W. Thiel et al. OLIGONUCLEOTIDES
- Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis
- (2008) P. Finetti et al. CANCER RESEARCH
- VRK1 phosphorylates CREB and mediates CCND1 expression
- (2008) T.-H. Kang et al. JOURNAL OF CELL SCIENCE
- Plk3 Interacts with and Specifically Phosphorylates VRK1 in Ser342, a Downstream Target in a Pathway That Induces Golgi Fragmentation
- (2008) I. Lopez-Sanchez et al. MOLECULAR AND CELLULAR BIOLOGY
- Human VRK1 Is an Early Response Gene and Its Loss Causes a Block in Cell Cycle Progression
- (2008) Alberto Valbuena et al. PLoS One
- Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets
- (2008) Katherine J. Martin et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search